Sprycel 70 MG Tablet is primarily used to manage specific types of blood cancers, particularly chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. It belongs to a class of medicines known as tyrosine kinase inhibitors.
This medicine is especially helpful when patients cannot tolerate or have not responded adequately to other conventional leukaemia treatments. It targets cancerous white blood cells that multiply uncontrollably due to genetic mutations, helping to control the progression of these serious blood disorders.
The medicine should be taken exactly as prescribed by your doctor, who will determine the appropriate dose based on your condition. Before beginning treatment, inform your doctor about any pre-existing medical conditions and any other medicines you are currently taking. Report any side effects promptly to your doctor and continue the medicine for the full duration prescribed, even if you begin to feel better.